Sinocare

Sinocare dominates the Chinese blood glucose monitoring market and ranks among the top four globally. Its portfolio includes hospital-grade and home-use blood glucose meters, uric acid/lipid/microalbumin test strips, non-invasive diabetes risk screening tools, continuous glucose monitors ("Sinocare iCan"), and integrated digital health solutions. Over half of diabetics in China use its products for self-monitoring. The company has expanded internationally through acquisitions of Trividia Health Inc. and PTS Diagnostics Inc., with a strong presence in both consumer and hospital markets. No clinical trial data as it focuses on diagnostics/devices rather than therapeutics.